Related by context. All words. (Click for frequent words.) 70 Liver transplantation 69 pharmacologic intervention 68 Surgical resection 67 Kidney transplantation 67 cytoreduction 67 adjuvant radiotherapy 67 Bone marrow transplantation 66 Lung transplantation 66 immunosuppressive regimens 66 Adjuvant chemotherapy 66 resectable 66 metastatic bladder 66 curative treatments 66 metastatic malignant 65 anti angiogenic agents 65 pelvic lymphadenectomy 65 curative resection 65 cranial irradiation 65 refractory angina 65 GIST tumors 65 immunosuppressive therapies 65 precancerous condition 65 malignant pleural mesothelioma 65 allogeneic HSCT 65 metastatic gastric 65 Radiofrequency ablation 65 PNH patients 65 indolent lymphomas 65 antithrombotic therapy 65 antiangiogenic agent 65 endocrine therapies 64 diagnostic modality 64 stratifying patients 64 thoracoscopic lobectomy 64 antimicrobial prophylaxis 64 transplantation HCT 64 spinal metastases 64 Inhaled nitric oxide 64 adverse cytogenetics 64 colorectal cancer liver metastases 64 chemotherapeutic regimens 64 skeletal metastases 64 colorectal liver metastases 64 metastatic kidney 64 androgen ablation 64 cardiotoxic 64 preoperative chemotherapy 64 TroVax ® 64 squamous cell lung cancer 64 cisplatin chemotherapy 64 Hepatocellular Carcinoma HCC 64 conventional angiography 64 MAGE A3 ASCI 64 anti angiogenic therapy 64 prostate carcinoma 64 antireflux surgery 64 neoadjuvant therapy 64 Venous thromboembolism 64 CTEPH 63 Chronic pancreatitis 63 Bezielle 63 recombinant interferon 63 liver metastasis 63 anthracycline therapy 63 renal tumors 63 chemopreventive agent 63 invasive candidiasis 63 cerebral vasospasm 63 chronic leukemias 63 oncologic outcomes 63 operable breast cancer 63 androgen deprivation 63 differentiated thyroid 63 recurrent glioblastoma multiforme 63 SEGAs 63 Carotid endarterectomy 63 Octreolin 63 systemic immunosuppressive drugs 63 ofpatients 63 cytoreductive surgery 63 Certolizumab pegol 63 perioperatively 63 immunomodulatory therapy 63 anagrelide 63 bronchogenic carcinoma 63 efficacious treatments 63 lymph node dissection 63 taxane refractory 63 cystectomy 63 portal vein thrombosis 63 medically inoperable 63 cytotoxic chemotherapy 63 unruptured aneurysm 63 Alessandro Riva 63 mutated K ras 63 CMV disease 63 hematopoietic cancers 63 ALI ARDS 63 prostate adenocarcinoma 62 IV tPA 62 liver resection 62 Umbilical cord stem cells 62 curative surgical resection 62 thromboembolic disease 62 neoadjuvant treatment 62 hepatorenal syndrome 62 antiarrhythmic drugs 62 ß blockers 62 adjuvant therapies 62 Gleevec resistant 62 vWD 62 Oral corticosteroids 62 ICD implantation 62 VTE prophylaxis 62 chronic thromboembolic pulmonary 62 β blockers 62 Hurthle cell 62 Cytolin R 62 cervical carcinoma 62 mitochondrial toxicity 62 candidemia 62 gastrointestinal stromal tumor 62 tuberous sclerosis TS 62 allogeneic bone marrow 62 radioiodine therapy 62 invasive diagnostic 62 autologous transplants 62 mTOR inhibitors 62 R0 resection 62 chronic granulomatous disease 62 relapsed SCLC 62 hoFH patients 62 aortic valve stenosis 62 chronic ITP patients 62 curative therapies 62 MyVax ® 62 thromboprophylaxis 62 LHRH agonists 62 intraperitoneal therapy 62 malabsorptive 62 malignant ascites 62 prognostic indicators 62 LVNC 62 Uncontrolled hypertension 62 perioperative morbidity 62 Cabazitaxel 62 Eisenmenger syndrome 62 lung resection 62 TMP SMX 62 revascularization procedure 62 acute GvHD 62 ximelagatran 62 oral anticoagulation 62 ADPKD 62 TNF antagonist 62 either acutely decompensated 62 samalizumab 62 hormone refractory 62 kidney urologic 62 cytotoxic therapy 62 clot busting therapy 62 unresectable tumors 62 cirrhosis liver failure 62 bowel resection 62 chronic myocardial ischemia 62 diagnostic biomarker 62 Torisel 62 ATIR 62 HER2 overexpression 62 carcinoid tumors 62 Glivec imatinib 62 Mitomycin C 62 antiplatelet medications 62 MYLOTARG 62 prostate TURP 62 TKI therapy 62 interferon beta therapy 62 CYT# potent vascular disrupting 62 surgical revascularization 62 pacemaker implantation 62 surgically resectable 62 anemias 61 metastatic malignant melanoma 61 immunopathology 61 rFVIIa 61 haematologic 61 interventional therapies 61 anticancer therapy 61 nonalcoholic steatohepatitis NASH 61 anti angiogenic drugs 61 epithelial tumors 61 antifungal therapy 61 prognostic indicator 61 recurrent glioblastoma 61 catheter angiography 61 intra arterial chemotherapy 61 induce remission 61 liver scarring 61 Balloon angioplasty 61 MMP inhibitors 61 KIACTA ™ 61 Gliadel Wafer 61 basal cell cancers 61 debulking surgery 61 polycythemia vera essential thrombocythemia 61 Polycythemia vera 61 locoregional recurrence 61 autologous transplantation 61 intravesical therapy 61 invasive carcinoma 61 mycophenolate mofetil 61 adeno associated viruses 61 nonmelanoma skin cancers 61 haematopoietic 61 DCVax R 61 Gleevec imatinib 61 treating neuropathic pain 61 decompensated cirrhosis 61 palliation 61 relapsed ovarian cancer 61 relapsed leukemia 61 radical nephrectomy 61 basal cell carcinoma BCC 61 Vidaza azacitidine 61 pemphigus vulgaris 61 BRAF inhibitors 61 infective endocarditis 61 oncological outcomes 61 Dr. Yair Lotan 61 bronchopulmonary dysplasia BPD 61 hypereosinophilic syndrome 61 stem cell transplantations 61 chemoresistant 61 Radical prostatectomy 61 sentinel lymph node biopsy 61 PCNSL 61 GISTs 61 prophylactic therapy 61 Glioblastoma Multiforme GBM 61 functional mitral regurgitation 61 Accelerated Partial Breast Irradiation 61 therapeutic regimens 61 herpes zoster vaccine 61 peritoneal cancer 61 nonsurgical treatment 61 adenomyosis 61 riociguat 61 malignant neoplasm 61 neuroendocrine cancers 61 hepatic metastases 61 thrombolytics 61 relapsed ALL 61 nonischemic 61 multimodality therapy 61 Immunosuppressive drugs 61 Chronic lymphocytic leukemia 61 antiangiogenic drugs 61 relapsing remitting MS RRMS 61 arterial thrombosis 61 LHRH receptor positive 61 antiplatelet therapies 61 smoldering multiple myeloma 61 Aggrastat ® tirofiban hydrochloride 61 refractory colorectal cancer 61 somatostatin analogues 61 mycophenolate 61 Hormonal therapy 61 chronic idiopathic thrombocytopenic purpura 61 taxane therapy 61 palliative radiotherapy 61 BrachySil TM 61 RhuDex TM 61 K ras mutations 61 pancreatic NET 61 surgical debulking 61 pharmacokinetic interactions 61 intravenous cyclophosphamide 61 thalidomide Thalomid 61 aromatase inhibitor therapy 61 myeloproliferative diseases 61 vascular insufficiency 61 imatinib Gleevec 61 basiliximab 61 Bacillus Calmette Guerin BCG 61 CMV reactivation 61 imatinib resistance 61 gastric adenocarcinoma 61 cranial radiation 61 prognostic marker 61 warfarin therapy 61 hereditary deficiency 61 plasminogen activators 61 tumor histology 61 lupus nephritis 61 locoregional 61 Pseudomonas aeruginosa infections 61 radiation sensitizer 61 Carotid stenting 61 EGFR inhibitors 61 SIR Spheres 61 cardiotoxicity 61 gastrointestinal stromal tumors GIST 61 chemoembolization 61 calcineurin inhibitors 61 Circulating tumor cells 61 thymectomy 61 colon resection 61 peritoneal carcinomatosis 61 postoperative radiotherapy 61 Combination therapy 60 haematological cancers 60 Trovax 60 Surgical excision 60 allogenic 60 resectable pancreatic cancer 60 metastatic neuroendocrine tumors 60 Xanafide 60 Islet transplantation 60 rtPA 60 AA Amyloidosis 60 patientswith 60 spontaneously regress 60 myeloablative 60 beta blocker therapy 60 Hydroxyurea 60 bladder carcinoma 60 AGILECT R 60 neutropenic patients 60 myelodysplastic myeloproliferative diseases 60 EGFR mutation positive 60 retransplantation 60 imatinib therapy 60 MYCN amplification 60 severe aortic stenosis 60 tyrosine kinase inhibitors TKIs 60 relapsed MM 60 epidural steroid injection 60 metastatic RCC 60 idiopathic myelofibrosis 60 pilocytic astrocytomas 60 Triptans 60 Acute Myeloid Leukaemia AML 60 carotid artery blockage 60 efaproxiral 60 Zevalin consolidation 60 invasive biopsy 60 Acute myeloid leukemia 60 Belldegrun 60 tissue plasminogen activator tPA 60 erlotinib Tarceva 60 de novo AML 60 paroxysmal AF 60 curable cancers 60 dissolving clots 60 elective PCI 60 Dasatinib 60 valve implantation 60 Heavy menstrual bleeding 60 gastric carcinoma 60 postoperative atrial fibrillation 60 sorafenib Nexavar 60 gastrointestinal stromal tumor GIST 60 perioperative complications 60 detecting colorectal cancer 60 anticlotting drugs 60 Aspergillus infections 60 Coronary artery bypass 60 oral antiplatelet 60 immunosuppressive medications 60 occlusive disease 60 neoadjuvant setting 60 Peginterferon alfa 2b 60 antiviral therapy 60 nonsmall cell lung cancer 60 prognostic markers 60 pancreatic neuroendocrine tumors 60 metaplasia 60 antitumor effect 60 antiepileptic medications 60 Allovectin 7 ® 60 postoperative pulmonary 60 androgen suppression 60 endovascular aneurysm repair 60 Temsirolimus 60 HbF 60 invasive fungal infection 60 KRAS oncogene 60 Adjuvant therapy 60 thrombolytic therapy 60 papillary renal cell carcinoma 60 Riluzole 60 Androgen deprivation therapy 60 Basal cell 60 Hurler syndrome 60 parathyroidectomy 60 antithrombotic agents 60 mRCC 60 thrombotic complications 60 chemotherapeutic treatments 60 refractory Hodgkin 60 gefitinib Iressa 60 hematologic disorders 60 TTF Therapy 60 decompensated heart failure 60 Severe Primary IGFD 60 ALK inhibitors 60 urothelial cancer 60 investigational therapies 60 pediatric acute lymphoblastic 60 sarcomatoid 60 fallopian tube carcinoma 60 nonmetastatic 60 micrometastases 60 monoclonal gammopathy 60 HER2 positive cancers 60 pancreatic adenocarcinoma 60 Pulmonary hypertension 60 diagnose Alzheimer disease 60 polyp recurrence 60 noninfectious uveitis 60 revascularization procedures 60 BCG refractory 60 ANCA associated 60 polyomavirus nephropathy 60 metastatic liver 60 immunosuppressed patients 60 Arsenic trioxide 60 Intravenous CP 60 receptor tyrosine kinase inhibitor 60 leukemia AML 60 prophylactic cranial irradiation 60 grade gliomas 60 osteosarcomas 60 efalizumab 60 anthracycline containing 60 orchitis 60 Noxafil 60 colorectal adenocarcinoma 60 VEGF inhibitors 60 urethral stricture 60 HIV coinfected 60 renal transplantation 60 receiving immunosuppressive therapy 60 immunodeficiency disorders 60 eflornithine 60 acute leukemias 60 alteplase 60 chemoradiotherapy 60 gastrointestinal stromal tumors 60 percutaneous ablation 60 Votrient 60 Sutent sunitinib 60 Chronic lymphocytic leukemia CLL 60 aromatase inhibitors AIs 60 immunosuppressant therapy 60 prostate cancer CaP 60 empiric treatment 60 remnant ablation 60 sleeve lobectomy 60 hepatocellular carcinomas 60 AFRS TM 60 thrombocytopenic 60 tigecycline 60 proteasome inhibitor 60 angiographically 60 pre malignant lesions 60 tumor resection 60 fusion enhancers 60 metastatic GIST 60 invasive aspergillosis 60 platelet inhibitor 60 osteoporotic vertebral compression fractures 60 myeloproliferative disorders 60 Alemtuzumab 60 medically refractory 60 radiochemotherapy 60 psoriatic arthritis PsA 60 precursor lesions 60 replacement TAVR 60 biologic plausibility 60 transcatheter aortic valve implantation 60 micrometastasis 60 therapeutic armamentarium 60 hyperoxaluria 60 dasatinib Sprycel 60 percutaneous cryoablation 59 solar keratoses 59 repair TEVAR 59 Sudhir Agrawal D.Phil 59 adenomatous polyps 59 Plaquenil 59 novel oral anticoagulant 59 biologic therapy 59 DVT prophylaxis 59 vandetanib 59 Ivabradine 59 intravenous bisphosphonates 59 antiarrhythmic medications 59 TNF blocker therapy 59 varices 59 SIADH 59 radioimmunotherapy RIT 59 hematological malignancy 59 immunosuppressive medication 59 CMV infection 59 Transcatheter aortic valve implantation 59 esophagectomy 59 resistant hormone refractory 59 prostate carcinomas 59 nitrofurantoin 59 chronic eosinophilic leukemia 59 symptomatic paroxysmal AF 59 hypervascular tumors 59 medullary thyroid cancer 59 curability 59 recurrent metastatic 59 urothelial bladder cancer 59 treat chronic sinusitis 59 esophagogastric 59 HoLEP 59 methotrexate therapy 59 mucinous 59 oral anticoagulant therapy 59 TKIs 59 neurogenic bladder 59 Candida infection 59 Campath alemtuzumab 59 renal scarring 59 radioembolization 59 CTAP# Capsules 59 LPLD 59 metastatic lung cancer 59 postoperative morbidity 59 Nicole Onetto MD 59 durable remissions 59 Minimally invasive surgery 59 neovascularisation 59 incidentalomas 59 recurrent prostate cancer 59 adjuvant therapy 59 minimally symptomatic 59 benign nodules 59 deletion 5q 59 diagnosed prenatally 59 non metastatic osteosarcoma 59 allogeneic hematopoietic stem cell 59 fulvestrant 59 RRMS patients 59 Systemic lupus erythematosus 59 gastroesophageal junction 59 therapeutic modality 59 immunomodulatory properties 59 superficial bladder cancer 59 postoperative chemotherapy 59 aneurysm rupture 59 graft occlusion 59 primary aldosteronism 59 Fingolimod 59 balloon brachytherapy 59 squamous cell histology 59 griseofulvin 59 pulmonary hypertension PH 59 alkylating agent 59 MELAS 59 Interferon beta 59 osteoporotic compression fractures 59 HIV HCV coinfected 59 pancreatic carcinoma 59 thrombophilia 59 cilengitide 59 prolongs survival 59 H. pylori infections 59 PTLD 59 autologous transplant 59 recurrent bladder 59 cediranib 59 antibiotic regimens 59 systemic toxicity 59 VALSTAR 59 AML acute myeloid 59 transarterial 59 lymphadenectomy 59 corticosteroid therapy 59 lipid lowering therapy 59 Advagraf 59 nonoperative treatment 59 RhuDex ® 59 allogeneic stem cell 59 Doxil ® 59 adjuvant cisplatin 59 cytotoxic effects 59 Li Fraumeni 59 renoprotective 59 hematologic abnormalities 59 targeted radiotherapeutic 59 AV fistulas 59 completely resected 59 5-fluorouracil/leucovorin 59 HBeAg negative 59 myocardial revascularization 59 axillary dissection 59 glucocorticoid therapy 59 EGFR blockers 59 antiangiogenic therapy 59 PFO closure 59 SERMs 59 nonalcoholic steatohepatitis 59 secondary amenorrhea 59 diabetic gastroparesis 59 angiogenic therapy 59 underlying pathophysiology 59 GRNOPC1 contains 59 immunomodulatory agents 59 recurrent GBM 59 Abatacept 59 Telintra 59 ReN# 59 generation purine nucleoside 59 Aortic stenosis 59 Catheter ablation 59 metastatic colorectal 59 dosing frequency 59 cabazitaxel 59 coronary intervention 59 reperfusion therapy 59 primary hyperparathyroidism 59 needle aspiration 59 clinically localized prostate 59 ECD kidneys 59 micafungin 59 LEUKINE 59 intravenous thrombolysis 59 haematopoietic stem cell 59 adrenalectomy 59 unresectable 59 invasive ductal breast cancer 59 hypertrophic scars 59 pancreatic cyst 59 pleural mesothelioma 59 Sebivo 59 IV NSCLC 59 sonographic diagnosis 59 presymptomatic 59 CA9 SCAN 59 aldosterone antagonists 59 refractory acute myeloid 59 AGHD 59 diabetic kidney 59 Aviptadil 59 cervical lymph nodes 59 pneumonectomy 59 malignant neoplasms 59 chronic periodontitis 59 leiomyomas 59 systemic corticosteroid 59 pulmonary resection 59 treat GI GVHD 59 ticagrelor Brilinta 59 EXJADE 59 Chronic hepatitis B 59 Prognostic factors 59 testosterone supplementation 59 pulmonary metastases 59 biphosphonates 59 hepatic toxicity 59 myelofibrosis 59 gastrointestinal GI cancers 59 noscapine 59 cervical lymph node 59 post thrombotic syndrome 59 oral talactoferrin 59 metastatic lesions 59 everolimus eluting stents 59 lymphomas leukemias 59 Glioblastoma Multiforme 59 antiarrhythmic drug 59 narrow QRS 59 imaging modality 59 pamidronate 59 droperidol 59 donor nephrectomy 59 grade cervical intraepithelial 59 immunomodulation 59 OHR/AVR# 59 metastatic lymph nodes 59 carcinoid 59 Vandetanib 59 antiarrhythmic 59 chemoradiation therapy 59 Mitral valve repair 59 MGUS 59 Papillary 59 thyroid nodules 59 Neuvenge 59 smoldering myeloma 59 masitinib 59 UPPP 59 malignant lesion 59 transplanted islets 59 Dabigatran 59 lung fibrosis 59 liver transplant recipients 59 revascularisation 59 PROCHYMAL 59 benign neoplasms 59 interferon ribavirin 59 thromboembolic 59 torsade de pointes 59 gastric cardia 59 intracranial stenosis 59 Smac mimetic 59 diagnosing coronary artery 59 Daclizumab 59 biliary tract cancer 59 humanised monoclonal antibody 59 pharmacological therapies 59 Factor Xa inhibitors 59 blood clot dissolving 59 reduce serum phosphate 59 hepatectomy 59 aortic root replacement 59 renovascular hypertension 59 neoplastic diseases 59 liposomal amphotericin B 59 malignant growths 59 NNRTIs 59 inhibit platelet function 59 raloxifene Evista 59 pre operatively 59 chemosensitivity 59 non resectable liver 59 chronic GVHD 59 Antibiotic prophylaxis 59 autologous SCT 59 histologic subtype 59 severe malignant osteopetrosis 59 cholangiocarcinoma 58 adriamycin 58 adult chronic ITP 58 systemic fungal infections 58 endovascular aneurysm repair EVAR 58 TransMID TM 58 beta interferon 58 biliary strictures 58 Candida infections 58 nephron sparing surgery 58 conformal radiotherapy 58 renal denervation 58 rheumatologic 58 HeFH 58 immunosuppressive regimen 58 hip resurfacing arthroplasty 58 ixabepilone 58 colon perforation 58 Nexavar sorafenib 58 bacterial prostatitis 58 Kantarjian 58 mutated KRAS gene 58 nephrotoxicity 58 deferiprone 58 allogenic stem cell 58 Cardiopulmonary bypass 58 noninvasive imaging 58 pulmonary toxicity 58 GP IIb IIIa inhibitors 58 myelofibrosis polycythemia vera 58 Alequel 58 aerosolized KL4 surfactant 58 Liver transplants 58 cell transplantation 58 BEXXAR Therapeutic Regimen 58 narrowed carotid arteries 58 paraganglioma 58 photodynamic treatment 58 MyVax 58 androgen ablation therapy 58 orchiectomy 58 solid organ transplantation 58 reslizumab 58 Gefitinib 58 QuadraSphere 58 type 1diabetes 58 Monoclonal antibody 58 conventional coronary angiography 58 stent grafting 58 cirrhotic patients 58 partial nephrectomy 58 Imatinib 58 Bevacizumab Avastin 58 underwent liver transplantation 58 G6PD deficiency 58 Gamma Knife surgery 58 monoclonal antibody therapies 58 drug ISA# 58 pituitary adenomas 58 epithelial ovarian 58 hepatocellular carcinoma liver 58 Poly ICLC 58 ano genital warts 58 uterine fibroid 58 colorectal adenoma 58 TNF alpha inhibitor 58 Inhaled insulin 58 K ras mutation 58 myelination disorders 58 vaginal hysterectomy 58 inhibit blood clotting 58 pharmacologic stress 58 lapatinib Tykerb 58 metastatic dermatofibrosarcoma protuberans DFSP 58 renal cell carcinomas 58 Teriparatide 58 postoperative delirium 58 Postoperative complications 58 calcineurin inhibitor 58 artery embolization 58 Fatty liver 58 Vitamin B# deficiency 58 YONDELIS 58 pediatric malignancies 58 localized prostate 58 Gemzar gemcitabine 58 carotid stenosis 58 thetreatment 58 carotid stents 58 nonpharmacologic 58 Radioimmunotherapy 58 pretransplant 58 ischemic mitral regurgitation 58 fibrate drugs 58 lipid lowering therapies 58 Pulmonary arterial hypertension 58 antibiotic prophylaxis 58 GBMs 58 histological subtype 58 gastroduodenal 58 preoperative diagnosis 58 pediatric Crohn disease 58 Delcath System 58 Neoadjuvant 58 noninvasive outpatient 58 HCV infections 58 unfavorable cytogenetics 58 sunitinib Sutent 58 beta lactam antibiotic 58 Sunitinib 58 Waldenstrom macroglobulinemia 58 histologically confirmed 58 prognostically 58 nonmelanoma 58 ZOLINZA 58 penicillin allergy 58 vitamin D analogs 58 neurologic complications 58 carotid artery stenting 58 Liprotamase 58 Aortic valve replacement 58 metastatic uveal melanoma 58 hemorrhagic complications 58 potentially hepatotoxic 58 pancreatic islet cell 58 stage IIIB 58 malignant lymphoma 58 mycosis fungoides 58 endovascular coiling 58 antiplatelet drugs 58 Pagoclone 58 imexon 58 hematopoietic cell 58 carcinoids 58 HeartNet 58 nonsurgical treatments 58 Vascugel 58 reoperations 58 NeuroFlo 58 protamine 58 Prenatal diagnosis 58 Metastatic breast cancer 58 total thyroidectomy 58 AA amyloidosis 58 taxane chemotherapy 58 anti tubercular 58 Hodgkin lymphoma HL 58 myeloproliferative neoplasms MPNs 58 precancerous cervical lesions 58 Tacrolimus 58 leukemia multiple myeloma 58 tension pneumothorax 58 clot dissolving drug 58 pulmonary artery banding 58 Balloon sinuplasty 58 FUSILEV enhances 58 thromboembolic events 58 predictive biomarkers 58 HER2 positive breast 58 Capsule endoscopy 58 NNRTI resistance 58 PLX cells 58 Ebstein anomaly 58 Src inhibitors 58 intensive statin therapy 58 immunosuppression therapy 58 Arranon 58 PARP inhibition 58 adjuvant trastuzumab 58 impair fertility 58 saphenous vein graft 58 metastatic medullary thyroid 58 lumiliximab 58 biliary stones 58 dyskeratosis congenita 58 PROLARIS 58 paricalcitol 58 benign prostatic hypertrophy BPH 58 allogeneic SCT 58 recurrent NSCLC 58 TNF inhibitor 58 carotid surgery 58 Zavesca R 58 chromosomal mutations 58 osteoporotic vertebral fractures 58 Hedgehog inhibitor 58 CVBT #H 58 venous thromboembolism prophylaxis 58 SLNB 58 alpha fetoprotein AFP 58 TRUS biopsy 58 T1a 58 Navelbine ® 58 tolevamer 58 glatiramer 58 synthetic grafts 58 multi factorial diseases 58 pheochromocytoma 58 renal cysts 58 Genetic predisposition 58 non ulcer dyspepsia 58 stem cell engraftment 58 aneuploidy screening 58 acute myeloid 58 clinically detectable 58 neuropsychological impairments 58 thromboembolic complications 58 thrombolytic agents 58 lupus renal disease 58 MEK inhibitors 58 Egrifta 58 porcine derived 58 bilateral orchiectomy 58 atherosclerotic disease 58 lung transplantation 58 EGFR TKI 58 HNSCC 58 thienopyridine 58 Sentinel node biopsy 58 asymptomatic hyperuricemia 58 benign biliary strictures 58 refractory metastatic 58 vemurafenib 58 XYOTAX TM 58 heparin induced thrombocytopenia 58 LV dysfunction 58 trabectedin 58 MGd 58 NAbs 58 Eculizumab 58 malignant pancreatic 58 antiangiogenesis 58 NSAID therapy 58 Ribavirin causes 58 trimethoprim sulfamethoxazole 58 sJIA 58 IPAH 58 Genasense ® 58 discogenic pain 58 blood clot dissolver 58 stage IIIB IV 58 hereditary predisposition 58 Mepact 58 lung metastasis 58 thymic carcinoma 58 artery stenosis 58 premalignant lesion 58 deCODE ProstateCancer TM 58 NPM1 mutation 58 Sorafenib 58 Li Fraumeni Syndrome 58 myelomas 58 laparoscopic partial nephrectomy 58 Myelodysplastic syndrome 58 dalteparin 58 Relapsing remitting MS 58 transplantation HSCT 58 Glioblastoma multiforme GBM 58 Temodar ® 58 extracapsular extension 58 lysosomal storage diseases 58 dexrazoxane 58 PLX STROKE targeting